Correlation Between CRISPR Therapeutics and Broadridge Financial

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Broadridge Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Broadridge Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Broadridge Financial Solutions,, you can compare the effects of market volatilities on CRISPR Therapeutics and Broadridge Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Broadridge Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Broadridge Financial.

Diversification Opportunities for CRISPR Therapeutics and Broadridge Financial

-0.45

Correlation Coefficient

CRISPR Therapeutics  Broadridge Financial

Very good diversification

The 3 months correlation between CRISPR and Broadridge is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Broadridge Financial Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Broadridge Financial and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Broadridge Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Broadridge Financial has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Broadridge Financial go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Broadridge Financial

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 68.01 times more return on investment than Broadridge Financial. However, CRISPR Therapeutics is 68.01 times more volatile than Broadridge Financial Solutions,. It trades about 0.02 of its potential returns per unit of risk. Broadridge Financial Solutions, is currently generating about 0.13 per unit of risk. If you would invest  3,099  in CRISPR Therapeutics AG on October 6, 2024 and sell it today you would earn a total of  53.00  from holding CRISPR Therapeutics AG or generate 1.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Broadridge Financial Solutions

CRISPR Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Broadridge Financial

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Broadridge Financial Solutions, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Broadridge Financial is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with CRISPR Therapeutics and Broadridge Financial

The main advantage of trading using opposite CRISPR Therapeutics and Broadridge Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Broadridge Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Broadridge Financial will offset losses from the drop in Broadridge Financial's long position.

The idea behind CRISPR Therapeutics AG and Broadridge Financial Solutions, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.